← Alle mensen

MR

Michael R Loken

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 juni 2025

CD33-splicingpolymorfisme bepaalt gemtuzumab ozogamicine-respons bij AML

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 augustus 2017

Gemtuzumab ozogamicine vermindert recidiefrisico bij FLT3/ITD acute myeloïde leukemie

Clinical cancer research : an official journal of the American Association for Cancer Research · 15 april 2016